The aryl hydrocarbon receptor (AhR) is a transcription factor involved in physiological processes, but also mediates most, if not all, toxic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Activation of the AhR by TCDD leads to its dimerization with aryl hydrocarbon nuclear translocator (ARNT) and transcriptional activation of several phase I and II metabolizing enzymes. However, this classical signalling pathway so far failed to explain the pleiotropic hazardous effects of TCDD, such as developmental toxicity and tumour promotion. Thus, there is an urgent need to define genetic programmes orchestrated by AhR to unravel its role in physiology and toxicology. Here we show that TCDD treatment of rat liver oval cells leads to induction of the transcription factor JunD, resulting in transcriptional upregulation of the proto-oncogene cyclin A which finally triggers a release from contact inhibition. Ectopic expression of cyclin A in confluent cultures overcomes G 1 arrest, indicating that increased cyclin A levels are indeed sufficient to bypass contact inhibition. Functional interference with AhR-, but not with ARNT, abolished TCDD-induced increase in JunD and cyclin A and prevented loss of contact inhibition. In summary, we have discovered a novel AhR-dependent and probably ARNT-independent signalling pathway involving JunD and cyclin A, which mediates TCDD-induced deregulation of cell cycle control.
Introduction
Cell proliferation is a highly regulated feedback control system, which is driven by responses to a number of different extracellular stimuli such as growth factors, but also involves surveillance mechanisms established by multiple check points to avoid unlimited growth. Important anti-proliferative signals are mediated by cell-cell contacts, which is referred to as contact-dependent inhibition of growth or contact inhibition (Eagle and Levine, 1967) . In adult tissues, contact inhibition is thought to be continuously active, playing a critical role in the repression of somatic cell proliferation. Release from contact inhibition in vivo is associated with abnormal cellular proliferation, that is cell transformation, tumour promotion and progression (Abercrombie, 1979) . In vitro, contact inhibition becomes apparent by the fact that adherent, nontransformed cells are arrested in G 1 phase at a critical cell density forming a confluent monolayer. In contrast, transformed cells are characterized by loss of contact inhibition manifested by a higher saturation density and the emergence of multi-layered foci. Despite its importance for cell cycle control, knowledge about the molecular mechanisms mediating contact inhibition and its deregulation during tumourigenesis is still scarce (Dietrich et al., 1997; Wieser et al., 1999; Heit et al., 2001; Faust et al., 2005) .
Loss of contact inhibition is often mediated by the action of tumour promoters. One of the most powerful tumour promoters ever tested in rodents is 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD), also known as dioxin (Pitot et al., 1980) . Epidemiological studies indicate that TCDD is also a human carcinogen (IARC, 1997) . TCDD is known to be the most potent ligand of an endogenous receptor, the aryl hydrocarbon receptor (AhR). The AhR is a ligand-activated transcription factor belonging to the basic helix-loop-helix/Per-ARNT-Sim family (Marlowe and Puga, 2005) . Binding of the ligand leads to nuclear translocation of the AhR, heterodimerization with aryl hydrocarbon nuclear translocator (ARNT) and subsequent binding of the AhR/ ARNT heterodimer to dioxin responsive elements, leading to transactivation of several genes encoding phase I and II xenobiotic metabolizing enzymes (for review see Nebert et al., 2004) . Studies in mice expressing a constitutively active AhR indicate that the AhR also plays a pivotal role in tumour promotion during liver carcinogenesis (Moennikes et al., 2004) . In addition, these mice show an increased incidence in the development of stomach tumours (Andersson et al., 2002) . This implies that activation of the AhR leads to a deregulation of cell cycle control in vivo. Although the AhR is involved in regulating cellular proliferation (Ma and Whitlock, 1996; Weiss et al., 1996; Kolluri et al., 1999) , the molecular mechanisms by which the AhR disturbs cell cycle control and supports tumour promotion are not completely understood so far (for review see Marlowe and Puga, 2005) .
In confluent rat liver WB-F344 cells, TCDD induces a release from contact inhibition (Mu¨nzel et al., 1996; Dietrich et al., 2002; Dietrich et al., 2003) accompanied by an increase in cyclin A/Cdk2 activity. In the present work we present a novel pathway whereby TCDD induces an increased abundance of the AP-1 transcription factor JunD, which in turn activates transcription of the cyclin A gene and thereby loss of contact inhibition. By using RNA-interference techniques and expression of dominant-negative mutants we show that this pathway is absolutely dependent on the AhR, but probably independent of ARNT.
Results

TCDD-induced loss of contact inhibition
Exposure of confluent WB-F344 cultures to TCDD (1 nM) for 48 h induces a loss of contact inhibition manifested by a twofold increase in saturation density (Figure 1a ) and the emergence of multi-layered foci (Dietrich et al., 2003) . Release from G 1 arrest is also shown by a twofold increase in the percentage of cells in S phase (1.9 ± 0.2, n ¼ 5) and G 2 /M phase (2.1 ± 0.33, n ¼ 5) ( Figure 1b ). That neither exponentially growing cells ( Figure 1a and Dietrich et al., 2002) nor serum-deprived cultures (Dietrich et al., 2002) respond to the growth stimulatory effect of TCDD indicates that TCDD does not exert a proliferative effect per se, but specifically interferes with the signalling cascade of contact inhibition.
Loss of contact inhibition by induction of cyclin A
We had previously shown that TCDD regulates cyclin A protein levels and activity specifically in confluent WB-F344 cultures (Figure 2a ; Supplementary Figure S1 and Dietrich et al., 2002) . Hence, no increase in cyclin A is seen in exponentially growing cells (60% confluence, 10% fetal calf serum (FCS)), or in serum-deprived cultures (60% confluence, 0% FCS) (Figure 2a and Supplementary Figure S1 ).
Semi-quantitative reverse transcription-PCR (RT-PCR) revealed an elevation of cyclin A mRNA levels in confluent cultures after TCDD exposure (12 h) (Figures 2b and Supplementary Figure S2 ). This increase in cyclin A mRNA could be blocked by the transcriptional inhibitor actinomycin D, suggesting that TCDD leads to a transcriptional activation of the cyclin A gene.
To investigate the causal role of cyclin A in overcoming G 1 arrest in contact inhibited cells, we established a doxycyclin-inducible system for ectopic expression of cyclin A in confluent cultures. Western blot analysis revealed that exposure to doxycyclin (2 mg ml À1 ) induces a four-to fivefold induction of cyclin A after 24 and 48 h, respectively ( Figure 2c ). Doxycyclin-induced expression of cyclin A led to a nearly fourfold induction of DNA synthesis as assessed by the incorporation of [ 3 H]thymidine ( Figure 2c ), demonstrating that elevation of cyclin A is indeed sufficient to overcome G 1 arrest in confluent WB-F344 cultures.
To prove that cyclin A mediates TCDD-induced release from contact inhibition, we downregulated cyclin A by transient transfection of siRNA. As depicted in Figure 2d , transfection of the specific siRNA led to a dramatic decrease in cyclin A protein levels and abrogated TCDD-dependent release from contact inhibition ( Figure 2d ).
Selective induction of JunD in response to TCDD
Cyclin A transcription is regulated by transcription factors of the AP-1 family (Casalino et al., 2007) . Interestingly, TCDD has been shown to increase mRNA levels of several AP-1 family members in mouse hepatoma cells (Puga et al., 1992; Hoffer et al., 1996) , and more recently our own studies proved an essential Loss of contact inhibition by the aryl hydrocarbon receptor C Weiss et al role of the AhR in induction of the AP-1 transcription factor c-Jun by TCDD in rat hepatoma cells . Thus, AP-1 proteins might be involved in transcriptional activation of cyclin A. Indeed, western blot analysis showed an increase in JunD levels (2.3±0.23, n ¼ 4) specifically in confluent WB-F344 cultures after TCDD exposure for 48 h (Figure 3a and Supplementary Figure S6 ), whereas in proliferating cells TCDD neither enhanced cyclin A nor JunD levels (Figure 2a and data not shown). Noteworthy, c-Jun or JunB abundance was not affected by TCDD treatment (Figure 3a) . Surprisingly, the induction of JunD and cyclin A was cell type-specific since no increase in JunD or cyclin A protein levels was observed in 5L rat or in Hepa1c1c7 mouse hepatoma cells (Figures 3b and c) . The effect of TCDD to induce JunD and cyclin A proteins and hence an increase in cell number in confluent cultures is not unique to WB-F344 cells, but was also detected in the commonly used and TCDDresponsive kidney epithelial cell line MDCK (Supplementary Figure S3 ). Thus, an increase in cyclin A levels by TCDD correlates with upregulated JunD hinting towards a possible cell type-specific function of JunD in TCDD-induced cyclin A expression. Exponentially growing (60% confluence, 10% fetal calf serum (FCS)), confluent (100% confluence, 10% FCS) or serum-deprived subconfluent (60% confluence, 0% FCS) WB-F344 cells were treated for 48 h with DMSO (controls) or TCDD (1 nM), and cyclin A was detected by western blot analysis (see also Supplementary Figure S1 ). (b) TCDD-induced increase in cyclin A mRNA is blocked by actinomycin D. Confluent WB-F344 cells were treated for 12 h with TCDD (1 nM) either in the absence or presence of actinomycin D (5 mg/ml). Semi-quantitative RT-PCR was performed using rat cyclin A-specific primers (see also Supplementary Figure S2 ). (c) Ectopic expression of cyclin A is sufficient to overcome contact inhibition. Confluent WB-F344 cells stably transfected with a vector encoding the doxycyclin-sensitive repressor Trex (pcDNA6/TR) and an expression plasmid containing the cDNA for murine cyclin A under the control of a Trex regulated promoter (pcDNA4/TO/ CycA) were treated for 24 or 48 h with doxycyclin (2 mg/ml) and cyclin A protein levels were monitored by western blotting. In a parallel experiment, in confluent, doxycyclin-treated and -untreated WB-F344 cells DNA synthesis was measured by the incorporation of [ 3 H]thymidine. Results are expressed as x-fold induction (ratio of counts of doxycyclin-treated compared to -untreated control cells) and given as means±s.e.m. (n ¼ 4-5). One representative experiment out of two is shown. Similar results were obtained in a second, independent clone (data not shown). Doxycyclin treatment of cells which were not transfected with the inducible cyclin A expression vector did not increase cyclin A expression, nor DNA synthesis (data not shown). (Figure 4a ). We therefore analysed whether endogenous JunD could bind to a previously described activating transcription factor (ATF)/cyclic AMP response element (CRE) consensus site of the rat cyclin A promoter (Shimizu et al., 1998) in response to TCDD. A biotinylated oligonucleotide probe, derived from the rat cyclin A promoter containing the functional ATF/CRE binding site specifically recovered JunD from TCDD-treated nuclear extracts (Figure 4b and Supplementary Figure S4 ). JunD forms heterodimers with other transcription factors of the Fos or ATF protein families (Shaulian and Karin, 2001) . DNA-affinity purification assays demonstrated increased binding of ATF2 to the ATF/CRE consensus site in response to TCDD (Figure 4b and Supplementary Figure S4 ), while Fra1, Fra2, c-Fos and FosB (Figure 4b ) could not be recovered.
To show that JunD indeed allows activation of the rat cyclin A promoter, we next performed reporter gene studies by transiently co-transfecting murine JunD-cDNA (pCMVjunD) and a luciferase reporter containing the 707 bp 5 0 -flanking region of the rat cyclin A gene (pcycAluc707-wt, Shimizu et al., 1998) . NIH3T3 cells were used since they show a higher transfection efficiency than WB-F344 cells. Expression of JunD led to a significant induction of luciferase activity in presence, but not absence, of a functional ATF/CRE binding site (Figure 4c ). Similar results were obtained in WB-F344 cells albeit with a lower transfection efficiency (Supplementary Figure S5) .
Direct binding of JunD to the cyclin A promoter in vivo was analysed by chromatin immunoprecipitation (ChIP) studies. Indeed, TCDD also significantly increased binding of JunD to the promoter of the endogenous cyclin A gene (Figure 4d ). Knockdown of AhR-, but not of ARNT-, expression interferes with JunD and cyclin A induction by TCDD Finally, we investigated the requirement of the AhR and ARNT in TCDD-induced loss of contact inhibition. Two independent approaches were followed to impair proper AhR and ARNT function: first, knockdown of the AhR and ARNT by transient transfection of siRNA and, second, stable expression of dominant-negative mutant proteins.
Transient transfection of siRNA targeted against AhR or ARNT mRNA resulted in a dramatic downregulation of the respective protein (Figure 5a ). As a functional consequence, TCDD-induced expression of the classical AhR/ARNT target protein CYP1A1 was drastically suppressed (Figure 5b) . Surprisingly, induction of cyclin A and JunD by TCDD was only reduced in the AhR-, but not ARNT-, knockdown cells (Figure 5b and Supplementary Figure S8 ). In accordance with the data obtained by using siRNA, TCDD-induced expression of CYP1A1 was dramatically reduced in cells expressing either a dn-AhR mutant protein lacking the transactivation domain (pAhRD495-805) or dn-ARNT mutant protein lacking the basic region (pARNTDb), but the increase in cyclin A and JunD protein levels was only abrogated in the dn-AhR, but not in the dn-ARNTexpressing clones. In analogous experiments, the presence of dn-AhR, but not of dn-ARNT, prevented an increase in mRNA levels of cyclin A by TCDD (data not shown). 
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To investigate the cellular consequence of blocking AhR or ARNT function, we analysed the release from contact inhibition in response to TCDD. The percentage of cells released from G 1 arrest by TCDD was significantly reduced only after knockdown of the AhR, but not of ARNT (Figure 5c ). Likewise, in cells expressing dn-AhR, but not dn-ARNT, TCDD-triggered release from contact inhibition was almost completely abrogated (Figure 5e ).
In summary, functional interference with AhR, but not ARNT, inhibits upregulation of JunD and cyclin A and subsequently impedes loss of contact inhibition by TCDD. We have revealed a novel AhR-dependent, and probably ARNT-independent pathway ( Figure 6 ) in which activation of the AhR induces an increase in JunD protein levels which together with ATF2 triggers transcriptional activation of the cyclin A gene, thereby leading to a loss of contact inhibition, that is deregulation of cell cycle control.
Discussion
The AhR mediates most, if not all, toxic responses to TCDD and probably other AhR ligands, such as polycyclic aromatic hydrocarbons (PAHs) and dioxinlike polychlorinated biphenyls (PCBs) (Bock and Kohle, 2005) . Although it is known that activation of the AhR leads to transcriptional induction of several xenobiotic metabolizing enzymes, such as CYP1A1 (for review see Nebert et al., 2004) , no mechanistic link could be established between CYP1A1 induction and tumour promotion. Moreover, in vivo studies in two genetically different rat strains indicate that indeed AhR-driven CYP1A1 induction and tumour promotion can be uncoupled from each other (reviewed in Tuomisto, 2005) . Thus, to understand the role of AhR in tumourigenesis there is the need to identify novel genetic programmes downstream of the receptor, which are apparently separable from CYP1A1 induction. In a search for such genes in 5L rat hepatoma cells we could recently identify cross talk of AhR with the p38 MAPK pathway causing induction of the AP-1 transcription factor family member c-Jun, which is unrelated to the action of AhR on CYP1A1 .
In the present work we have identified a novel pathway in WB-F344 rat liver oval cells, whereby activation of the AhR leads to induction of yet another member of the AP-1 family of transcription factors, JunD, which in turn activates transcription of cyclin A finally leading to a release from contact inhibition. Interestingly, exposure of WB-F344 to other AhR ligands such as PAHs and PCBs also upregulates cyclin A followed by loss of contact inhibition (Chramostova et al., 2004; Vondracek et al., 2005) . Figure S8 ). (c) DNA synthesis was measured by the incorporation of [ 3 H]thymidine. (d, e) Confluent cultures of stably transfected clones (dn-AhR, dn-ARNT or the corresponding vector control expressing clones) were treated with TCDD for 48 h. (d) Induction of CYP1A1, JunD and cyclin A protein levels was determined by western blotting (e) In parallel, cell number was determined and results are expressed as described in Figure 1a . *Po0.05, ***Po0.001, n.s., not significant.
Loss of contact inhibition by the aryl hydrocarbon receptor C Weiss et al
In rat fibroblasts, serum-induced increase in cyclin A expression is mediated by a JunD/ATF2 complex binding to the ATF/CRE site in the cyclin A promoter (Shimizu et al., 1998) . In the present work we showed that deregulation of cyclin A via JunD acting on the ATF/CRE site is key to loss of contact inhibition provoked by the tumour promoter TCDD. As we could also observe binding of ATF2 to the ATF/CRE site in the DNA-affinity purification assay and since knockdown of ATF2 protein by RNA interference inhibits TCDD-dependent cyclin A induction, it is likely that JunD binds to this site as a heterodimer together with ATF2. Besides the described ATF/CRE site, several additional binding sites have been recently described to be critical for regulation of the rat cyclin A promoter by AP-1 (Casalino et al., 2007) , which may also contribute to TCDD-induced cyclin A induction.
Interestingly, JunD protects cells from UV and bacterial lipopolysaccharide-induced apoptosis in vitro and in vivo (Weitzman et al., 2000) . This observation provides a hypothetical, but intriguing link between JunD induction observed after TCDD exposure in WB-F344 cells and the described anti-apoptotic response to TCDD treatment in UV-exposed hepatocytes in vitro (Wo¨rner and Schrenk, 1996) and decreased apoptosis during TCDD-induced tumour promotion in vivo (Stinchcombe et al., 1995) .
The mechanism of AhR-dependent JunD induction has not been studied yet. Comparison with the published sequence of the murine JunD promoter (de Groot et al., 1991) reveals 87% homology with the corresponding 5 0 -flanking region of the rat JunD gene, which contains three potential XREs. Puga and co-workers have shown that two isolated XREs derived from the mouse JunD promoter when cloned in front of a minimal SV40 promoter drive expression of a reporter gene (Puga et al., 1992; Hoffer et al., 1996) . However, the functional relevance of these XREs in regulating the endogenous JunD promoter has not been elucidated so far.
As outlined above, it is conceivable that the genes downstream of the AhR involved in tumour promotion are different from CYP1A1. Interestingly, downregulating ARNT-function blocks TCDD-dependent induction of CYP1A1, the classical AhR-ARNT mediated pathway, but does not abrogate upregulation of JunD or cyclin A nor the release from contact inhibition. Thus, AhR affects JunD and contact inhibition presumably independent of ARNT and highlights the possibility of AhR influencing cellular programmes such as contact inhibition and possibly tumour promotion by novel non-conventional mechanisms.
Loss of contact inhibition in response to TCDD is cell type-specific as it takes place in several cell lines such as WB-F344 liver oval cells, MDCK kidney and human squamous carcinoma cells (Hebert et al., 1990) , but not, for example, in 5L rat hepatoma cells. Similar observations of highly cell type-dependent actions of TCDD have been observed previously for example, inhibition of proliferation in primary and transformed hepatocytes and thymocytes (Hushka and Greenlee, 1995; Weiss et al., 1996; Kolluri et al., 1999) and centrilobular hepatocytes, but increased proliferation of, for example, periportal hepatocytes in vivo (Fox et al., 1993) . Understanding the cell type-specific responses to TCDD is instrumental to uncover the basis for the known cell type and organ specificity of TCDD poisoning (for recent reviews Bock and Kohle, 2005; Marlowe and Puga, 2005) .
Mechanistic studies on liver carcinogenesis and also studies on the role of the AhR in cell cycle control have mainly focussed on hepatocytes and hepatoma cells so far. Very recently, Hailey et al. (2005) published a 2-year exposure study in which rats had been exposed to TCDD or dioxin-like compounds. These results suggest for the first time that oval cells might be targets of TCDD action during liver carcinogenesis. Oval cells, that is liver stem cells, function as a regenerative reservoir in acute liver damage (for review see Shafritz and Dabeva, 2002; ) and may give rise to liver tumours in rodents and humans (Steinberg et al., 1994; Libbrecht et al., 2000; Dumble et al., 2002) . WB-F344 cells (Tsao et al., 1984) are the best characterized oval cells available so far (for review see Shafritz and Dabeva, 2002) . When transplanted in vivo, they fully differentiate into hepatocytes (Coleman et al., 1997) . Moreover, transplantation of chemically transformed WB-F344 cells results in the formation of hepatocarcinomas, cholangiocarcinomas and hepatoblastomas (Tsao and Grisham, 1987) . Accordingly, WB-F344 cells are a relevant stem cell culture model to mechanistically study the tumour-promoting effects of TCDD and the AhR.
In summary, we have discovered in rat liver oval cells a novel AhR-dependent and probably ARNT-independent signalling pathway involving JunD and cyclin A, which mediates deregulation of contact inhibition by TCDD. 
Materials and methods
Materials
Plasmids
To create a doxycyclin-inducible cyclin A expression plasmid, a HindIII/XbaI fragment derived from pCMVcyclinA (Hinds et al., 1992;  kindly provided by E Knudsen) was cloned into pcDNA4/TO (Clontech) prepared by digestion with HindIII and XbaI. pcDNA6/TR, pPUR (Clontech), pCMVjunD (pMT163, Musti et al., 1996;  kindly provided by AM Musti), pcycAluc707-wt, pcycAluc707-mut (Shimizu et al., 1998;  kindly provided by A Takeuchi), dn-AhR (pAhRD495-805, Chang and Puga, 1998 ; kindly provided by A Puga), dn-ARNT (pARNTDb, Mason et al., 1994;  kindly provided by RH Wenger).
Cell culture WB-F344 cells (kindly provided by KW Bock, Tuebingen, Germany) were cultured and treated as previously described (Dietrich et al., 2002) .
Western blotting
Western blot analysis was performed as described (Heit et al., 2001; Faust et al., 2005) . Quantification of western blot signals was performed using NIH Image (version 1.61).
Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was carried out as described (Dietrich et al., 2003) . For primers and PCR conditions see Supplementary data S9.
Measurement of DNA synthesis DNA synthesis was determined by [ 3 H]thymidine incorporation as described (Dietrich et al., 1996) .
Determination of cell number
Cells were washed, trypsinized and counted in a hemocytometer.
Reporter gene assay NIH3T3 or WB-F344 cells were co-transfected at 50-70% confluence in 96-well plates with pcycAluc707-wt or pcycA-luc707-mut (100 ng per well) and pCMVjunD (500 ng per well) by lipofectamine according to the manufacturer's instructions.
Control cells were co-transfected with pcycAluc707-wt or pcycAluc707-mut (100 ng per well) and pCDNA3 (500 ng per well). Transfection efficiency was controlled by co-transfection with a ubiquitin promoter-driven Renilla luciferase construct (10 ng per well) as described (Weiss et al., 2003) .
Transfection of plasmids and siRNA Transient transfection of siRNA was performed as described . Detailed information on transfection of siRNA and plasmids is given in Supplementary data S9.
DNA-affinity purification assay
Nuclear extracts were performed as described by Andrews and Faller (1991) . Equal amounts of nuclear proteins (100-200 mg) were incubated with 2 mg of biotinylated double-stranded oligonucleotides for 5 min at 30 1C followed by incubation for 30 min on ice. Oligonucleotide-protein complexes were recovered using streptavidin-conjugated agarose (1 h, 4 1C) and then washed extensively. The following double-stranded oligonucleotides containing either a wild-type or a mutated ATF/CRE site (underlined) were used: (ATF/CRE wt) 5 0 -biotinGCG ACCGGCGCTCCTG GTGACGTCACTGGCCCCGA-3 0 or (ATF/CRE mut) 5 0 -biotinGCGACCGGCGCTCCT GGTGT GGTCACTGGCCCCGA-3 0 . Proteins bound to DNA were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analysed by western blotting.
ChIP assay
ChIP assay was carried out according to Upstates Biology's protocol for the ChIP assay kit with some minor modifications (see Supplementary data S9).
Statistical analysis
The results are expressed as means ± s.e.m. The significance of difference between two mean values was assessed by Student's t-test. For the comparison of more than two mean values, a one-way analysis of variance was performed followed by a Bonferroni's test. A Po0.05 was taken to be statistically significant.
